FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4295067101> ?p ?o ?g. }

• W4295067101 abstract "The treatment of HR+/HER2- metastatic breast cancer with cyclin-dependent kinases 4 and 6 inhibitors combined with endocrine therapy has recently emerged as the most relevant therapeutic strategy. However, in routine clinical practice, the best therapeutic approach in patients with comorbidities at early relapsing or ab initio metastatic disease, PI3KCA mutation, is still debated among oncologists. Given these areas of uncertainty, we conducted a Delphi survey to describe and confront the level of agreement or disagreement between clinicians working in referral vs local spoke oncological hospitals and summarize a consensus on these debated topics. In total, 56 items were drafted using the Nominal Group Technique and used for the Delphi Survey. A total of 46 clinicians participated in the survey. Overall, the consensus threshold among all participants was reached in 46/56 items (82%), and Delphi Survey results showed a high level of consensus. For the 10 items (18%) that did not reach the consensus threshold, possible explanations considering differences in clinical practice and recent findings from literature are provided in the Discussion. Outcomes from the present survey may help guide treatment in multiple comorbidities, early recurring and ab initio metastatic disease, and PI3KCA mutation, where evidence from randomized trials and level 1 evidence is currently missing." @default.
• W4295067101 created "2022-09-10" @default.
• W4295067101 creator A5001498807 @default.
• W4295067101 creator A5003897511 @default.
• W4295067101 creator A5006857854 @default.
• W4295067101 creator A5009976972 @default.
• W4295067101 creator A5014990363 @default.
• W4295067101 creator A5027353243 @default.
• W4295067101 creator A5030013928 @default.
• W4295067101 creator A5030465858 @default.
• W4295067101 creator A5031414207 @default.
• W4295067101 creator A5034632931 @default.
• W4295067101 creator A5034676299 @default.
• W4295067101 creator A5043599930 @default.
• W4295067101 creator A5046176016 @default.
• W4295067101 creator A5050243893 @default.
• W4295067101 creator A5050476736 @default.
• W4295067101 creator A5074479074 @default.
• W4295067101 creator A5078562748 @default.
• W4295067101 date "2022-09-09" @default.
• W4295067101 modified "2023-09-30" @default.
• W4295067101 title "Controversial topics in metastatic HR+/HER2- breast cancer: Guiding treatment by a modified Delphi approach" @default.
• W4295067101 cites W1969861179 @default.
• W4295067101 cites W2102118972 @default.
• W4295067101 cites W2141414987 @default.
• W4295067101 cites W2192816303 @default.
• W4295067101 cites W2320248812 @default.
• W4295067101 cites W2404884142 @default.
• W4295067101 cites W2552099557 @default.
• W4295067101 cites W2556970382 @default.
• W4295067101 cites W2560635244 @default.
• W4295067101 cites W2796824128 @default.
• W4295067101 cites W2802776309 @default.
• W4295067101 cites W2804105316 @default.
• W4295067101 cites W2896846857 @default.
• W4295067101 cites W2905067827 @default.
• W4295067101 cites W2910972034 @default.
• W4295067101 cites W2920014560 @default.
• W4295067101 cites W2945564879 @default.
• W4295067101 cites W2948069739 @default.
• W4295067101 cites W2972049666 @default.
• W4295067101 cites W2972122997 @default.
• W4295067101 cites W2976415870 @default.
• W4295067101 cites W2977565884 @default.
• W4295067101 cites W2981795130 @default.
• W4295067101 cites W3043082495 @default.
• W4295067101 cites W3115380088 @default.
• W4295067101 cites W3120241209 @default.
• W4295067101 cites W3133509869 @default.
• W4295067101 cites W3136518379 @default.
• W4295067101 cites W3141372695 @default.
• W4295067101 cites W3167855488 @default.
• W4295067101 cites W3203674089 @default.
• W4295067101 cites W3212930043 @default.
• W4295067101 cites W3215519201 @default.
• W4295067101 cites W4200066800 @default.
• W4295067101 cites W4200440627 @default.
• W4295067101 cites W4206666777 @default.
• W4295067101 doi "https://doi.org/10.3389/fonc.2022.950861" @default.
• W4295067101 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36158652" @default.
• W4295067101 hasPublicationYear "2022" @default.
• W4295067101 type Work @default.
• W4295067101 citedByCount "0" @default.
• W4295067101 crossrefType "journal-article" @default.
• W4295067101 hasAuthorship W4295067101A5001498807 @default.
• W4295067101 hasAuthorship W4295067101A5003897511 @default.
• W4295067101 hasAuthorship W4295067101A5006857854 @default.
• W4295067101 hasAuthorship W4295067101A5009976972 @default.
• W4295067101 hasAuthorship W4295067101A5014990363 @default.
• W4295067101 hasAuthorship W4295067101A5027353243 @default.
• W4295067101 hasAuthorship W4295067101A5030013928 @default.
• W4295067101 hasAuthorship W4295067101A5030465858 @default.
• W4295067101 hasAuthorship W4295067101A5031414207 @default.
• W4295067101 hasAuthorship W4295067101A5034632931 @default.
• W4295067101 hasAuthorship W4295067101A5034676299 @default.
• W4295067101 hasAuthorship W4295067101A5043599930 @default.
• W4295067101 hasAuthorship W4295067101A5046176016 @default.
• W4295067101 hasAuthorship W4295067101A5050243893 @default.
• W4295067101 hasAuthorship W4295067101A5050476736 @default.
• W4295067101 hasAuthorship W4295067101A5074479074 @default.
• W4295067101 hasAuthorship W4295067101A5078562748 @default.
• W4295067101 hasBestOaLocation W42950671011 @default.
• W4295067101 hasConcept C105795698 @default.
• W4295067101 hasConcept C111919701 @default.
• W4295067101 hasConcept C121608353 @default.
• W4295067101 hasConcept C126322002 @default.
• W4295067101 hasConcept C143998085 @default.
• W4295067101 hasConcept C19527891 @default.
• W4295067101 hasConcept C2775930923 @default.
• W4295067101 hasConcept C2776135927 @default.
• W4295067101 hasConcept C2779134260 @default.
• W4295067101 hasConcept C2779495148 @default.
• W4295067101 hasConcept C33923547 @default.
• W4295067101 hasConcept C41008148 @default.
• W4295067101 hasConcept C512399662 @default.
• W4295067101 hasConcept C530470458 @default.
• W4295067101 hasConcept C535046627 @default.
• W4295067101 hasConcept C60641444 @default.
• W4295067101 hasConcept C71924100 @default.
• W4295067101 hasConceptScore W4295067101C105795698 @default.

• next